Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Rahul Banerjee is a physician-researcher who specializes in bone marrow and blood stem cell transplantation as well as cellular immunotherapies for the treatment of blood cancers. He has a particular interest in multiple myeloma, which results in the overproduction of blood components of the immune system known as plasma cells. Dr. Banerjee also treats patients with AL amyloidosis, a related but rarer condition that is treated similarly through close collaboration between cancer doctors, kidney doctors, and heart doctors. Those treatments may include transplantation using a reinfusion of a patient’s own blood stem cells or the use of CAR T cell therapies, where the patient’s stem cells are genetically modified to respond to the condition. In addition to novel treatments for multiple myeloma and AL amyloidosis, Dr. Banerjee's research interests involve digital health and supportive care to help patients as they undergo these treatments.
Assistant Professor
Division of Medical Oncology, University of Washington
Member, Content Committee
American Society for Transplantation and Cellular Therapy (ASTCT)
Member, Plasma Cell Disorders Working Committee
Center for International Blood & Marrow Transplant Research (CIBMTR)
2021-2022, Advanced Fellowship, BMT and Cellular Therapy, University of California San Francisco (UCSF), San Francisco, CA
2018-2021, Fellowship, Hematology/Oncology University of California San Francisco (UCSF), San Francisco, CA
2017-2018, Chief Residency (Quality Improvement), Internal Medicine, Philadelphia VA Medical Center, Philadelphia, PA
2014-2017, Residency, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
2010-2014, M.D., Alpert Medical School, Brown University, Providence, RI
2006-2010, Sc.B., Brown University, Providence, RI, (Magna Cum Laude)
Multiple Myeloma
Chimeric Antigen Receptor T-cell (CAR-T) therapy
Digital health
Patient-reported outcomes
Multiple Myeloma
AL amyloidosis
Chimeric Antigen Receptor T-cell (CAR-T) therapy
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210